A recent meta-analysis examining long-term mortality in subjects who participated in
controlled studies evaluating the impact of daily aspirin on vascular risk, has concluded that …

Aspirin inhibits the enzyme cyclooxygenase (Cox), and there is a significant body of
epidemiological evidence demonstrating that regular aspirin use is associated with a …

Experimental, epidemiological, and clinical data from the last two decades have each
supported the hypothesis that aspirin possesses anticancer properties, and that its use may …

We comprehensively reviewed the published scientific literature on non-steroidal anti-
inflammatory drugs (NSAIDs) and cancer and evaluated results based upon epidemiologic …

Over the last 2 years, data from prospective trials have consolidated the pre-existing
evidence from epidemiological and observational studies that suggest that aspirin has …

The seminal epidemiological observation that nonsteroidal anti-inflammatory drugs
(NSAIDs) prevent colon and possibly other cancers has spurred novel approaches to cancer …

This paper briefly reviews the pharma-cologic effects of nonsteroidal antiinflammatory drugs
(NSAIDs) that influence the risks and benefits of using these drugs prophylactically for …

Epidemiological and experimental studies have demonstrated the effect of non-steroidal anti-
inflammatory drugs (NSAIDs) in the prevention of human cancers. NSAIDs block …

Clinical guidelines for prophylactic aspirin use currently only consider the cardiovascular
benefits of aspirin, weighed against the potential harm from aspirin-induced bleeding. Daily …

Chemoprevention refers to the use of natural or synthetic agents to reverse, suppress, or
prevent the progression or recurrence of cancer. A large body of preclinical and clinical data …